BriaCell: An Emerging Immuno-Oncology Company
August 14, 2023 at 12:24 PM EDT
BriaCell has recently announced agreement with the FDA for their pivotal, registration trial in advanced metastatic breast cancer.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|